Editorial
Axillary surgery after neoadjuvant therapy: rethinking completion axillary dissection for residual micrometastatic disease
Translational Cancer Research
2026;
15
(4)
:225
.
(30 April 2026)
Original Article
Establishing the role of the neurotransmitter receptor-related gene GABRD in the diagnosis, prognosis and immune infiltrates of colorectal cancer by bioinformatics analysis and experimental validation
Translational Cancer Research
2026;
15
(4)
:226
.
(30 April 2026)
Serum amyloid A1 promote progression of breast cancer and is associated with epithelial-mesenchymal transition
Translational Cancer Research
2026;
15
(4)
:227
.
(30 April 2026)
Association of primary lesion surgery and surgical modality with overall survival in patients with stage IV cutaneous melanoma: a population-based study
Translational Cancer Research
2026;
15
(4)
:228
.
(30 April 2026)
Impact of the immuno-oncology era on cerebrovascular disease and cancer-specific mortality in older adults with advanced non-small cell lung cancer: a competing-risks cohort study
Translational Cancer Research
2026;
15
(4)
:229
.
(30 April 2026)
Development and validation of a multi-task deep learning model integrating PET-CT radiomics, clinical variables, and EBV DNA for prognostic prediction in locally advanced nasopharyngeal carcinoma
Translational Cancer Research
2026;
15
(4)
:230
.
(30 April 2026)
Investigation of immunohistochemical marker expression in breast cancer of varying severity and construction of a predictive model
Translational Cancer Research
2026;
15
(4)
:231
.
(30 April 2026)
Identifying research gaps in PIK3CA-mutant breast cancer: a bibliometric analysis of evolving trends and clinical applications
Translational Cancer Research
2026;
15
(4)
:232
.
(30 April 2026)
PD-1-targeted therapeutic strategies for advanced or recurrent gastric and gastroesophageal junction cancer: a systematic review and network meta-analysis
Translational Cancer Research
2026;
15
(4)
:233
.
(30 April 2026)
Analyses of single-cell and bulk RNA-sequencing datasets identify biomarker-based molecular subtypes and a prognostic signature in lung adenocarcinoma
Translational Cancer Research
2026;
15
(4)
:234
.
(30 April 2026)
PTTG1-DLX2 axis drives malignant progression of lung adenocarcinoma by activating the WNT/β-catenin signaling pathway
Translational Cancer Research
2026;
15
(4)
:235
.
(30 April 2026)
Dairy product consumption and thyroid cancer risk: a systematic review and meta-analysis of observational studies
Translational Cancer Research
2026;
15
(4)
:236
.
(30 April 2026)
Integrating multiple omics and machine learning to reveal the prognostic value of endoplasmic reticulum stress gene FKBP10 in gastric cancer
Translational Cancer Research
2026;
15
(4)
:237
.
(30 April 2026)
The role of the CDCA gene family in tumor stemness maintenance and drug sensitivity
Translational Cancer Research
2026;
15
(4)
:238
.
(30 April 2026)
Identification of a novel ion channel-related gene signature to predict prognosis and immune response of gastric cancer
Translational Cancer Research
2026;
15
(4)
:239
.
(30 April 2026)
Single-cell and bulk transcriptomic analyses identify B-cell senescence-associated biomarkers in papillary thyroid carcinoma
Translational Cancer Research
2026;
15
(4)
:240
.
(30 April 2026)
Establishment and evaluation of a prognostic model for sodium overload necrosis in acute myeloid leukemia
Translational Cancer Research
2026;
15
(4)
:241
.
(30 April 2026)
Molecular mechanism of miR-27a-3p targeting FBXW7 regulating the malignant behavior of osteosarcoma cells
Translational Cancer Research
2026;
15
(4)
:242
.
(30 April 2026)
Black ginseng extract suppresses lung cancer growth in a xenograft mouse model
Translational Cancer Research
2026;
15
(4)
:243
.
(30 April 2026)
Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
Translational Cancer Research
2026;
15
(4)
:244
.
(30 April 2026)
Overexpression of FOXO1 may suppress proliferation and migration and correlate with tumor immune cells in nasopharyngeal carcinoma
Translational Cancer Research
2026;
15
(4)
:245
.
(30 April 2026)
The obesity paradox effect of triglyceride-glucose-body mass index (TyG-BMI) on all-cause mortality in patients with malignant tumors: a machine learning-driven cohort study
Translational Cancer Research
2026;
15
(4)
:246
.
(30 April 2026)
Plasma fatty acid associated with risk of gastrointestinal cancer: a prospective cohort study from UK Biobank
Translational Cancer Research
2026;
15
(4)
:247
.
(30 April 2026)
Knockdown of TRIM35 suppresses cell proliferation and metastasis by modulating the PPAR signalling pathway in papillary thyroid cancer cells
Translational Cancer Research
2026;
15
(4)
:248
.
(30 April 2026)
Lipid metabolism-related gene expression predicts prognostic outcomes in lung adenocarcinoma
Translational Cancer Research
2026;
15
(4)
:249
.
(30 April 2026)
Translational progress and bottlenecks in neurotransmitter-cancer research [2000–2025]: an integrated bibliometric and interventional trial analysis
Translational Cancer Research
2026;
15
(4)
:250
.
(30 April 2026)
Construction of an actin cytoskeleton-related gene signature for predicting prognosis and therapeutic response in glioblastoma: based on machine learning
Translational Cancer Research
2026;
15
(4)
:251
.
(30 April 2026)
Overexpression of ACTL6A is associated with poor prognosis in gastric cancer, and nuclear level is an independent predictor
Translational Cancer Research
2026;
15
(4)
:252
.
(30 April 2026)
A novel risk model of cholesterol metabolism-related mRNAs for predicting overall survival and immune signature in glioma based on machine learning and multi-omics data
Translational Cancer Research
2026;
15
(4)
:253
.
(30 April 2026)
Non-coding RNAs (ncRNAs)-mediated high expression of Ras-related C3 botulinum toxin substrate 1 (RAC1) correlates with poor prognosis and tumor immune infiltration of liver hepatocellular carcinoma
Translational Cancer Research
2026;
15
(4)
:254
.
(30 April 2026)
Results of the feasibility study of clinical trials of the new cancer treatment technology Karanahan for patients with advanced breast cancer
Translational Cancer Research
2026;
15
(4)
:255
.
(30 April 2026)
Long non-coding RNA (lncRNA) CDKN2A-DT promotes proliferation, migration, and invasion of oral squamous cell carcinoma via the PI3K/AKT/mTOR axis
Translational Cancer Research
2026;
15
(4)
:256
.
(30 April 2026)
CLIP2 is a potential biomarker for platinum resistance and prognosis in ovarian cancer: a bioinformatics analysis
Translational Cancer Research
2026;
15
(4)
:257
.
(30 April 2026)
OSBPL3 promotes colorectal cancer progression through modulation of TGF-β signaling and immune cell infiltration
Translational Cancer Research
2026;
15
(4)
:258
.
(30 April 2026)
A2M promotes the progression of STAD by upregulating vimentin expression and epithelial-mesenchymal transition: boinformatics analysis and experimental verification
Translational Cancer Research
2026;
15
(4)
:259
.
(30 April 2026)
Nomogram prediction for breast cancer-specific survival in patients with ER−/PR−/HER2+ breast cancer: an analysis based on the SEER population
Translational Cancer Research
2026;
15
(4)
:260
.
(30 April 2026)
Integrated transcriptomic analysis and machine learning identify immunogenic cell death genes as prognostic markers and therapeutic targets in non-small cell lung cancer
Translational Cancer Research
2026;
15
(4)
:261
.
(30 April 2026)
Optimization of temporal phase in multi-phase contrast-enhanced MRI for gross tumor volume determination in pancreatic cancer radiotherapy
Translational Cancer Research
2026;
15
(4)
:262
.
(30 April 2026)
Development and multicenter validation of an immunoinflammatory marker-MRI model for pathological complete response after neoadjuvant chemotherapy in invasive breast cancer
Translational Cancer Research
2026;
15
(4)
:263
.
(30 April 2026)
Integrating single-cell and spatial transcriptomics to decipher the neuro-immune microenvironment of breast cancer brain metastasis: a key regulatory axis, prognostic model, and drug discovery
Translational Cancer Research
2026;
15
(4)
:264
.
(30 April 2026)
Construction of a prognostic risk model based on colorectal cancer-specific ferroptosis genes and preliminary validation of FGFR4
Translational Cancer Research
2026;
15
(4)
:265
.
(30 April 2026)
Ferroptosis-related lncRNA signature predicts prognosis and treatment response in colon cancer
Translational Cancer Research
2026;
15
(4)
:266
.
(30 April 2026)
UBA6 serves as a prognostic biomarker and promotes tumor progression in pancreatic ductal adenocarcinoma
Translational Cancer Research
2026;
15
(4)
:267
.
(30 April 2026)
Metaxins regulate cancer stem cell-like properties in H1299 cells
Translational Cancer Research
2026;
15
(4)
:268
.
(30 April 2026)
Multi-omics analysis identifies RARRES1 as a potential biomarker linked to immunosuppressive microenvironment and its radiomics prediction in ovarian cancer
Translational Cancer Research
2026;
15
(4)
:269
.
(30 April 2026)
Tertiary lymphoid structure-related genes drive tumor microenvironment heterogeneity and prognostic disparities in left- vs. right-sided colon cancer
Translational Cancer Research
2026;
15
(4)
:270
.
(30 April 2026)
A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes
Translational Cancer Research
2026;
15
(4)
:271
.
(30 April 2026)
Asporin promotes gastric cancer progression by regulating NRF2 ubiquitination and competitively binding to KEAP1
Translational Cancer Research
2026;
15
(4)
:272
.
(30 April 2026)
Multi-omics clustering combined with multiple machine learning to identify epigenetic features in low-grade glioma patients
Translational Cancer Research
2026;
15
(4)
:273
.
(30 April 2026)
Chromatin remodeling-driven stratification and a five-gene RiskScore define proliferative aggressiveness and therapeutic vulnerabilities in neuroblastoma
Translational Cancer Research
2026;
15
(4)
:274
.
(30 April 2026)
Exploring the significance of IgM expression in the lymphatic system during breast cancer progression
Translational Cancer Research
2026;
15
(4)
:275
.
(30 April 2026)
Construction and external validation of a nomogram for predicting 10-year recurrence risk after radical resection in Chinese patients with stage III colorectal cancer
Translational Cancer Research
2026;
15
(4)
:276
.
(30 April 2026)
Integrated analysis of the prognostic and immunotherapeutic significance of ZEB1-AS1 in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(4)
:277
.
(30 April 2026)
Radiation-activated astrocytes promote tumor progression through CXCL12 secretion and induce resistance to anti-PD-1 immunotherapy
Translational Cancer Research
2026;
15
(4)
:278
.
(30 April 2026)
Deciphering the molecular crosstalk between pancreatic ductal adenocarcinoma and type 2 diabetes through multi-dataset integration
Translational Cancer Research
2026;
15
(4)
:279
.
(30 April 2026)
Lysine crotonylation-related long non-coding RNAs: a novel prognostic framework for gastric carcinoma
Translational Cancer Research
2026;
15
(4)
:280
.
(30 April 2026)
Development and validation of a non-invasive nomogram for predicting bone metastasis in newly diagnosed breast cancer
Translational Cancer Research
2026;
15
(4)
:281
.
(30 April 2026)
Magnetic resonance imaging-based radiomics analysis: predicting vascular invasion in breast invasive ductal carcinoma using different machine learning models
Translational Cancer Research
2026;
15
(4)
:282
.
(30 April 2026)
Bioinformatics analysis of PBLD as a potential biomarker in pan-cancer and colon adenocarcinoma
Translational Cancer Research
2026;
15
(4)
:283
.
(30 April 2026)
Establishment and validation of a novel anoikis-related prognostic signature of lung squamous cell carcinoma
Translational Cancer Research
2026;
15
(4)
:284
.
(30 April 2026)
Identification of EFNA family as new potential prognostic biomarkers correlated with immune cell infiltration in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(4)
:285
.
(30 April 2026)
Dexamethasone and N-acetylcysteine for the prevention of post-embolization syndrome following transarterial chemoembolization in hepatocellular carcinoma: a systematic review and network meta-analysis
Translational Cancer Research
2026;
15
(4)
:286
.
(30 April 2026)
Baseline neutrophil-to-lymphocyte ratio as a prognostic biomarker in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(4)
:287
.
(30 April 2026)
DNPEP promotes the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through RACK1/ERK signaling pathway
Translational Cancer Research
2026;
15
(4)
:288
.
(30 April 2026)
Identification of immune-related gene signature for predicting prognosis of glioblastoma patients
Translational Cancer Research
2026;
15
(4)
:289
.
(30 April 2026)
Construction of a diagnostic model for colorectal cancer based on exosome-related genes: integration of immune cell differentials and molecular docking
Translational Cancer Research
2026;
15
(4)
:290
.
(30 April 2026)
Identification of shared diagnostic biomarkers and molecular pathways between chronic kidney disease and renal cell carcinoma using transcriptomics and machine learning
Translational Cancer Research
2026;
15
(4)
:291
.
(30 April 2026)
An exploratory study on whole-lung radiomics features from computed tomography for prognostic prediction in non-small cell lung cancer with concurrent chemoradiotherapy
Translational Cancer Research
2026;
15
(4)
:292
.
(30 April 2026)
Digitoxin inhibits the growth of HSC-3 cells by inducing G2/M cell cycle arrest and apoptosis
Translational Cancer Research
2026;
15
(4)
:293
.
(30 April 2026)
Mitochondrial gene APOO reprograms lipid metabolism to influence the prognosis of breast cancer
Translational Cancer Research
2026;
15
(4)
:294
.
(30 April 2026)
Prognostic value and therapeutic implications of HMGA2 in EGFR-mutant non-small cell lung cancer
Translational Cancer Research
2026;
15
(4)
:295
.
(30 April 2026)
Lipid metabolism-related molecular typing and prognostic characteristics of cutaneous melanoma
Translational Cancer Research
2026;
15
(4)
:296
.
(30 April 2026)
Diagnostic performances of skin cancers using intensity- and gradient-based features with optical coherence tomography: a pilot study
Translational Cancer Research
2026;
15
(4)
:297
.
(30 April 2026)
Lysosome-dependent cell death reveals a prognostic signature in colorectal cancer via integrated analysis of scRNA-seq and bulk RNA-seq data
Translational Cancer Research
2026;
15
(4)
:298
.
(30 April 2026)
A prognostic model based on Scissor+ cancer-associated macrophages identified from bulk and single cell RNA sequencing data in ovarian cancer
Translational Cancer Research
2026;
15
(4)
:299
.
(30 April 2026)
Development and internal validation of a multivariable prognostic prediction model in advanced breast cancer patients based on the SEER database
Translational Cancer Research
2026;
15
(4)
:300
.
(30 April 2026)
Prediction of distant metastasis and survival of appendiceal cancer patients: a SEER population-based study
Translational Cancer Research
2026;
15
(4)
:301
.
(30 April 2026)
Preoperative prediction of HER2 expression in gastric cancer based on an enhanced CT radiomics model
Translational Cancer Research
2026;
15
(4)
:302
.
(30 April 2026)
Metformin suppressed epithelial-mesenchymal transition, cisplatin resistance and metastatic potential of ovarian cancer via inhibiting TGF-β1/Smads
Translational Cancer Research
2026;
15
(4)
:303
.
(30 April 2026)
Tirzepatide attenuates doxorubicin-induced cardiotoxicity via mitochondrial function improvement
Translational Cancer Research
2026;
15
(4)
:304
.
(30 April 2026)
IGF2BP3 promotes immune evasion and predicts poor prognosis in head and neck squamous cell carcinoma
Translational Cancer Research
2026;
15
(4)
:305
.
(30 April 2026)
Clinical and prognostic implications of KRT19 expression in pancreatic ductal adenocarcinoma
Translational Cancer Research
2026;
15
(4)
:306
.
(30 April 2026)
Identification and analysis of endoplasmic reticulum stress- related genes in neuroblastoma and construction of a prognostic gene signature
Translational Cancer Research
2026;
15
(4)
:307
.
(30 April 2026)
A distinct form of colorectal cancer: signet ring cell carcinoma
Translational Cancer Research
2026;
15
(4)
:308
.
(30 April 2026)
Explainable machine-learning prediction of overall and cancer-specific survival in adult triple-negative breast cancer using SEER: a comparative study of nomograms and random survival forests
Translational Cancer Research
2026;
15
(4)
:309
.
(30 April 2026)
Machine learning-based early survival prediction in early-onset hepatocellular carcinoma: a SEER-based multi-model comparative study
Translational Cancer Research
2026;
15
(4)
:310
.
(30 April 2026)
Nomogram for predicting cancer-specific mortality risk in endometrial cancer after postoperative radiotherapy
Translational Cancer Research
2026;
15
(4)
:311
.
(30 April 2026)
Identification and validation of ZAP70 as a potential biomarker associated with T cell infiltration in lung adenocarcinoma
Translational Cancer Research
2026;
15
(4)
:312
.
(30 April 2026)
Clinical features, central nervous system risk, and therapeutic outcomes in primary sinonasal diffuse large B-cell lymphoma: a retrospective cohort study of 94 patients
Translational Cancer Research
2026;
15
(4)
:313
.
(30 April 2026)
Integrated single-cell and bulk RNA sequencing reveals novel biomarkers of invasive adenocarcinoma subtypes in lung adenocarcinoma
Translational Cancer Research
2026;
15
(4)
:314
.
(30 April 2026)
Clinical outcomes and prognostic factors of systemic therapy combined with interventional treatment in hepatocellular carcinoma: a multicenter retrospective case series
Translational Cancer Research
2026;
15
(4)
:315
.
(30 April 2026)
The effects of adjuvant radiotherapy on survival outcomes in polymorphous adenocarcinoma: a retrospective cohort study
Translational Cancer Research
2026;
15
(4)
:316
.
(30 April 2026)
RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1
Translational Cancer Research
2026;
15
(4)
:317
.
(30 April 2026)
MTFR2 regulated the proliferation, apoptosis, migration, and invasion of endometrial cancer cells through the Drp1/MFN1 signaling pathway mediated mitochondrial fission
Translational Cancer Research
2026;
15
(4)
:318
.
(30 April 2026)
Survival benefit of adjuvant radiotherapy for gallbladder cancer patients with stage IIIA: a population based, propensity score-matched study
Translational Cancer Research
2026;
15
(4)
:319
.
(30 April 2026)
Exosomal P4HA3: a promising biomarker for diagnosis and prognosis in gastric cancer
Translational Cancer Research
2026;
15
(4)
:320
.
(30 April 2026)
The effect of astragaloside IV on doxorubicin-induced cardiotoxicity in young mice: exploring its cardioprotective effect during childhood tumor chemotherapy
Translational Cancer Research
2026;
15
(4)
:321
.
(30 April 2026)
Loss of GGT6 promotes colorectal cancer progression and correlates with poor prognosis: a study based on multi-database mining and functional validation
Translational Cancer Research
2026;
15
(4)
:322
.
(30 April 2026)
Comprehensive analysis and validation of the prognostic value of glycosylation- and mitophagy-related genes for head and neck squamous cell carcinoma
Translational Cancer Research
2026;
15
(4)
:323
.
(30 April 2026)
LncRNA ELFN1-AS1 promotes colon cancer occurrence and progression by regulating the miR-191-5p/ZBTB34 axis
Translational Cancer Research
2026;
15
(4)
:324
.
(30 April 2026)
Clinical value and cost-effectiveness analysis of conditionally approved anticancer drugs in China from 2015 to 2023
Translational Cancer Research
2026;
15
(4)
:325
.
(30 April 2026)
The potential of ATF5 as a prognostic marker and therapeutic target in cancer: insights from bioinformatics analysis and experimental validation
Translational Cancer Research
2026;
15
(4)
:326
.
(30 April 2026)
Clinical significance of circulating tumor DNA monitoring based on TP53 mutation in high-grade serous ovarian cancer patients
Translational Cancer Research
2026;
15
(4)
:327
.
(30 April 2026)
Tree-based model for diffuse-type gastric cancer prognostication: a population study based on the Surveillance, Epidemiology, and End Results database
Translational Cancer Research
2026;
15
(4)
:328
.
(30 April 2026)
Network pharmacology approach and experimental verification of Danzhi Xiaoyao Powder for breast cancer treatment based on UHPLC-Q-Orbitrap HRMS
Translational Cancer Research
2026;
15
(4)
:329
.
(30 April 2026)
Development and validation of a macrophage-related prognostic model for overall survival in ovarian cancer via integrated RNA sequencing analysis
Translational Cancer Research
2026;
15
(4)
:330
.
(30 April 2026)
A machine learning-based basement membrane gene signature model for predicting ovarian cancer survival
Translational Cancer Research
2026;
15
(4)
:331
.
(30 April 2026)
Adaptive radiotherapy based on nodal response to induction chemotherapy in nasopharyngeal carcinoma: a retrospective dose de-escalation analysis
Translational Cancer Research
2026;
15
(4)
:332
.
(30 April 2026)
Physical activity and cancer survival: the role of peripheral blood immune and inflammatory markers in reducing mortality—a retrospective cohort study based on NHANES 1999–2018
Translational Cancer Research
2026;
15
(4)
:333
.
(30 April 2026)
Characterizing immune heterogeneity in gastric cancer by high-throughput T-cell receptor sequencing: predictive clonotypes and functional signatures
Translational Cancer Research
2026;
15
(4)
:334
.
(30 April 2026)
Fibulin-5 (FBLN5) as a context-dependent pan-cancer regulator: integrated multi-omics analysis reveals dual roles in tumor progression and therapeutic resistance
Translational Cancer Research
2026;
15
(4)
:335
.
(30 April 2026)
Review Article
Targeting “undruggable” cancer proteins: pharmacological challenges and emerging strategies
Translational Cancer Research
2026;
15
(4)
:336
.
(30 April 2026)
A narrative review of cinobufacini for endometrial cancer: mechanisms and therapeutic implications
Translational Cancer Research
2026;
15
(4)
:337
.
(30 April 2026)
Tumor cell plasticity in non-small cell lung cancer: the role of microRNA and implications for diagnosis, prognosis and treatment
Translational Cancer Research
2026;
15
(4)
:338
.
(30 April 2026)
The double-edged sword of tumor-targeted treatment: the influence of targeted therapy on the heart
Translational Cancer Research
2026;
15
(4)
:339
.
(30 April 2026)
CRISPR technology in ovarian cancer research: advances from gene editing to precision diagnosis and therapy
Translational Cancer Research
2026;
15
(4)
:340
.
(30 April 2026)
Metronomic chemotherapy combined with immunotherapy in solid tumor: a systematic review
Translational Cancer Research
2026;
15
(4)
:341
.
(30 April 2026)
Targeting the MICA/B-NKG2D axis in cancer: from molecular structure to immunotherapeutic strategies—a narrative review
Translational Cancer Research
2026;
15
(4)
:342
.
(30 April 2026)
Precision, prevention and progress: charting two decades of change in gynaecological oncology—a narrative review
Translational Cancer Research
2026;
15
(4)
:343
.
(30 April 2026)
PARP inhibitors in the treatment of ovarian cancer: a narrative review
Translational Cancer Research
2026;
15
(4)
:344
.
(30 April 2026)
Editorial Commentary
Starving leukemia: nicotinamide phosphoribosyltransferase-dependent nicotinamide adenine dinucleotide salvage links metabolic vulnerability to therapeutic sensitivity in acute myeloid leukemia
Translational Cancer Research
2026;
15
(4)
:345
.
(30 April 2026)
Postoperative proton therapy in uterine and cervical cancer: promising evidence but remaining questions
Translational Cancer Research
2026;
15
(4)
:346
.
(30 April 2026)
From prognosis to precision: interpreting HER2DX assay in early HER2-positive breast cancer
Translational Cancer Research
2026;
15
(4)
:347
.
(30 April 2026)
Can whole genome data analysis be used to personalize breast cancer care?
Translational Cancer Research
2026;
15
(4)
:348
.
(30 April 2026)
Post-transplant oral decitabine and cedazuridine maintenance in high-risk acute myeloid leukemia or myelodysplastic syndrome
Translational Cancer Research
2026;
15
(4)
:349
.
(30 April 2026)
Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?
Translational Cancer Research
2026;
15
(4)
:350
.
(30 April 2026)
Anti-HCV treatment and risk for extrahepatic cancers: evidence of benefits with questions remaining
Translational Cancer Research
2026;
15
(4)
:351
.
(30 April 2026)
Risk-reducing surgery, risk-reducing medication, and surveillance in young BRCA carriers with breast cancer: considering all the options
Translational Cancer Research
2026;
15
(4)
:352
.
(30 April 2026)
Iodine seed-marking protocol for response-guided axillary de-escalation after neoadjuvant therapy in node-positive breast cancer
Translational Cancer Research
2026;
15
(4)
:353
.
(30 April 2026)
Too much, too soon?—trastuzumab deruxtecan in the first line metastatic setting
Translational Cancer Research
2026;
15
(4)
:354
.
(30 April 2026)
Residual disease after neoadjuvant therapy in HER2-positive breast cancer: biology, burden, or both?
Translational Cancer Research
2026;
15
(4)
:355
.
(30 April 2026)
Refining breast cancer risk estimation in carriers of pathogenic BRCA2 variants
Translational Cancer Research
2026;
15
(4)
:356
.
(30 April 2026)
Sentinel lymph node biopsy in early-stage oral squamous cell carcinoma: reassessing its role in contemporary practice
Translational Cancer Research
2026;
15
(4)
:357
.
(30 April 2026)
Moderately hypofractionated IMPT with pelvic nodal irradiation for high-risk prostate cancer: an emerging standard or an incremental step?
Translational Cancer Research
2026;
15
(4)
:358
.
(30 April 2026)
Small device, big impact: how a simple chairside 3D-printed retractor reshapes dose and patient experience in head and neck radiotherapy
Translational Cancer Research
2026;
15
(4)
:359
.
(30 April 2026)
